VisualMED has closed its agreement with Rennova Health
Company has now completed acquisition of medical software and technology assets.
RENO, Nev. - June 29, 2021 - PRLog -- VisualMED Clinical Solutions Corp. (The "Company") announces completion of its acquisition to merge Rennova Health (RNVA) software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into VisualMED. These entities will operate as wholly owned subsidiaries of VisualMED. In order to mark this major evolution, The Company will immediately proceed to complete a name and trading symbol change.
VisualMED will be completing all required filings to become compliant with SEC reporting requirements and become a fully reporting Company.
VisualMed intend to take the necessary steps to comply with the relevant regulations and rules to permit Rennova to distribute shares in VisualMED to its shareholders at some time in the future.
VisualMED, a clinical information company, owns a portfolio of valuable intellectual property. The company and its partners' university affiliates are world leaders in Artificial Intelligence which help support our process to create intelligent applications for home use. Patients will be able to monitor serious health and medical issues, helping to reduce medical errors and negligence that put millions of patients in harm's way every year in North America.
About Rennova Health, Inc.
Rennova operates rural hospitals and a physician's office in Tennessee and a physician's office in Kentucky and provides industry-leading diagnostics and supportive software solutions to healthcare providers. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com
VisualMED Clinical Solutions
FORWARD-LOOKING STATEMENTS: Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.